Analgesic properties of the novel amino acid, isovaline
- PMID:20357156
- DOI: 10.1213/ANE.0b013e3181d27da2
Analgesic properties of the novel amino acid, isovaline
Erratum in
- Anesth Analg. 2013 Jan;116(1):257
Abstract
Background: Isovaline, a nonproteinogenic alpha-amino acid rarely found in the biosphere, is structurally similar to the inhibitory neurotransmitters glycine and gamma-aminobutyric acid. Because glycine(A) and gamma-aminobutyric acid receptor agonists are antiallodynic, we hypothesized that isovaline produces antinociception in mice.
Methods: All experiments were performed on female CD-1 mice using a blinded, randomized, and controlled design. The effects of RS-isovaline were studied on nociceptive responses to (1) formalin injection into the hindpaw; (2) glutamate injection into the hindpaw; and (3) strychnine injection either into the lumbar intrathecal space or cisterna magna. We determined the effects of IV RS-isovaline (50, 150, or 500 mg/kg; n = 10/dose) or intrathecal RS-, R-, and S-isovaline, glycine, and beta-alanine into the lumbar intrathecal space (5-microL volumes of 60, 125, 250, and 500 mM; n = 9/dose/group) on the response to formalin in the paw. The response to 20 microL intraplantar glutamate (750 mM) was compared with glutamate (750 mM) coadministered with isovaline. We also determined the response to intraplantar strychnine. Lumbar intrathecal (100 microM) or intracisternal (200 microM) injections of strychnine into the lumbar intrathecal space or the cisterna magna were used to induce allodynia as a measure of glycine inhibitory dysfunction. The effects of intrathecal or intracisternal strychnine were compared with isovaline coapplied with the strychnine (n = 8/group).
Results: In the formalin paw test, IV isovaline did not change phase I but decreased phase II responses in a dose-dependent manner (50% effective dose = 66 mg/kg, n = 10, P < 0.01). There was no effect on rotarod performance, appearance, or behavior of the mouse, and no respiratory depression. Intrathecal isovaline, glycine, and beta-alanine attenuated phase I and II responses (P < 0.01 for each drug). In contrast to beta-alanine and glycine, isovaline at maximally effective doses did not produce scratching, biting, or agitation. Intrathecal RS- and S-isovaline attenuated phase I (P < 0.05 for each group) and RS-, R-, and S-isovaline attenuated phase II responses (P < 0.05 for each group), with no significant difference between the efficacies of R- and S-enantiomers. Localized strychnine-induced glycine inhibitory dysfunction was greatly reduced by intracisternal (P < 0.01) and intrathecal (P < 0.01) isovaline. Although intraplantar strychnine did not induce peripheral allodynia, high doses of isovaline did not block the peripheral allodynia induced by glutamate.
Conclusions: Isovaline reduced responses in mouse pain models without producing acute toxicity, possibly by enhancing receptor modulation of nociceptive information.
Similar articles
- N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system.Quintão NL, da Silva GF, Antonialli CS, de Campos-Buzzi F, Corrêa R, Filho VC.Quintão NL, et al.Anesth Analg. 2010 Mar 1;110(3):942-50. doi: 10.1213/ANE.0b013e3181cbd7f6.Anesth Analg. 2010.PMID:20185671
- Evaluation of a novel mouse model of intracisternal strychnine-induced trigeminal allodynia.Lee IO, Whitehead RA, Ries CR, Schwarz SK, Puil E, MacLeod BA.Lee IO, et al.Can J Anaesth. 2013 Aug;60(8):780-6. doi: 10.1007/s12630-013-9975-x. Epub 2013 Jun 6.Can J Anaesth. 2013.PMID:23740428
- GABA(B) receptor-mediated selective peripheral analgesia by the non-proteinogenic amino acid, isovaline.Whitehead RA, Puil E, Ries CR, Schwarz SK, Wall RA, Cooke JE, Putrenko I, Sallam NA, MacLeod BA.Whitehead RA, et al.Neuroscience. 2012 Jun 28;213:154-60. doi: 10.1016/j.neuroscience.2012.04.026. Epub 2012 Apr 21.Neuroscience. 2012.PMID:22525135
- Isovaline causes inhibition by increasing potassium conductance in thalamic neurons.Cooke JE, Mathers DA, Puil E.Cooke JE, et al.Neuroscience. 2009 Dec 15;164(3):1235-43. doi: 10.1016/j.neuroscience.2009.08.045. Epub 2009 Aug 28.Neuroscience. 2009.PMID:19720114
- Spinal drug delivery.Grabow TS, Derdzinski D, Staats PS.Grabow TS, et al.Curr Pain Headache Rep. 2001 Dec;5(6):510-6. doi: 10.1007/s11916-001-0068-0.Curr Pain Headache Rep. 2001.PMID:11676885Review.
Cited by
- Transmission pathways and mediators as the basis for clinical pharmacology of pain.Kirkpatrick DR, McEntire DM, Smith TA, Dueck NP, Kerfeld MJ, Hambsch ZJ, Nelson TJ, Reisbig MD, Agrawal DK.Kirkpatrick DR, et al.Expert Rev Clin Pharmacol. 2016 Oct;9(10):1363-1387. doi: 10.1080/17512433.2016.1204231. Epub 2016 Jul 4.Expert Rev Clin Pharmacol. 2016.PMID:27322358Free PMC article.
- Isovaline does not activate GABA(B) receptor-coupled potassium currents in GABA(B) expressing AtT-20 cells and cultured rat hippocampal neurons.Pitman KA, Borgland SL, MacLeod B, Puil E.Pitman KA, et al.PLoS One. 2015 Feb 23;10(2):e0118497. doi: 10.1371/journal.pone.0118497. eCollection 2015.PLoS One. 2015.PMID:25706125Free PMC article.
- Assessment of Biochemical and Neuroactivities of Cultural Filtrate fromTrichoderma harzianum in Adjusting Electrolytes and Neurotransmitters in Hippocampus of Epileptic Rats.Abd El-Rahman AA, El-Shafei SMA, Shehab GMG, Mansour L, Abuelsaad ASA, Gad RA.Abd El-Rahman AA, et al.Life (Basel). 2023 Aug 28;13(9):1815. doi: 10.3390/life13091815.Life (Basel). 2023.PMID:37763219Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical